Ligand Pharmaceuticals/ US53220K5048 /
| 2025-01-14 9:59:55 PM | Chg. +2.61 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 108.29USD | +2.46% | 3,182 Turnover: 339,931.82 |
-Bid Size: - | -Ask Size: - | 2.05 bill.USD | - | 35.94 |
GlobeNewswire
2024-08-13
Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
GlobeNewswire
2024-08-12
iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of ...
GlobeNewswire
2024-05-14
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
2024-05-06
The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire
2024-03-28
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
GlobeNewswire
2024-03-08
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
2024-01-11
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel End...
GlobeNewswire
2023-12-12
Sermonix Pharmaceuticals Shares Pharmacokinetic and Baseline Genomic Clinical Data Tied to ELAINE La...
GlobeNewswire
2023-12-12
Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient...
GlobeNewswire
2023-12-11
Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of O...
GlobeNewswire
2023-12-01
Palvella Therapeutics and Ligand Pharmaceuticals Expand Strategic Partnership to Accelerate Phase 3 ...
GlobeNewswire
2023-11-28
Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Brea...
GlobeNewswire
2023-11-06
Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete R...
GlobeNewswire
2023-11-03
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
GlobeNewswire
2023-10-18
Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest i...
GlobeNewswire
2023-10-02
Sermonix Pharmaceuticals Shares Results of EQUALS 2 Survey on Vaginal and Sexual Health in Patients ...
GlobeNewswire
2023-10-02
Sermonix Pharmaceuticals Announces Results of ELAINE-1 Exploratory Analysis Evaluating Effect of Pat...
GlobeNewswire
2023-09-05
Sermonix Pharmaceuticals Shares Encore ELAINE-2 Poster Presentation at 2023 Metastatic Breast Cancer...
GlobeNewswire
2022-03-24
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Emclaire Fi...
GlobeNewswire
2022-02-22
Novan Reports Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2022-02-18
Organovo Welcomes New Sr. Vice President of Strategy and Business Development
